Last year, Cardiff, U.K.-based Verona secured £44.7 million ($65.6 million) from big-name investors on both sides of the Atlantic for work on its PDE3/PDE4…

Chinese CRO Newsummit Biopharma has received a license to a hepatitis C antibody from MRC Technology, a medical research charity.

Many CROs are turning their studies to vast populated Asian countries, boosting the region’s trial industry, a recent Frost & Sullivan report finds.

PPD has secured a renewal of a decades-long research assistance contract with the Division of AIDS within the NIH’s National Institute of Allergy and…

PPD rolled out a new hub to oversee all rare disease and pediatric drug development activities, as the world observes Rare Disease Day on the last day of…

German CRO-biotech hybrid Evotec and England’s Oxford University have granted their first set of awards that will help fund projects targeting CV and…

AmerisourceBergen’s IntrinsiQ Specialty Solutions and ION Solutions have launched a clinical trial recruitment network, bringing healthcare providers and…

PRA Health has further integrated itself into Takeda’s research business. The CRO will now also work with the Big Pharma in its native Japan under a joint…

R&D